| 1 |
33064914 | Programmed cell death 1-expressing CD56-negative natural killer (NK) cell expansion is a hallmark of chronic NK cell activation during dasatinib treatment. | 2021 Feb |
7 |
| 2 |
30405627 | Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and Function. | 2018 |
4 |
| 3 |
22211798 | Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinib. | 2012 Jun |
1 |
| 4 |
22730528 | Dasatinib enhances the expansion of CD56+CD3- NK cells from cord blood. | 2012 Jun 21 |
1 |